Autoimmune Disease Diagnostics Market By Product (Consumables & Assay Kits, Instruments, Software & Services), By Test Type (Antinuclear Antibody Tests, Autoantibody Tests, C-Reactive Protein Tests, Erythrocyte Sedimentation Rate Tests, Complete Blood Count, Others), By Technology (ELISA, Radioimmunoassay, Immunofluorescence Assay, Multiplex Assays, Immuno), By Disease Type (Systemic Autoimmune Diseases {Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Scleroderma}, Organ-Specific Autoimmune Diseases {Type 1 Diabetes, Hashimoto’s Thyroiditis, Graves’ Disease, Celiac Disease, Multiple Sclerosis, Others}), By End-user (Hospitals, Clinical Laboratories, Diagnostic Centers, Research Institutes).Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles, and Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Autoimmune Disease Diagnostics Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Increasing prevalence of autoimmune diseases is driving global diagnostic test demand growth

3.2.2. Rising awareness among patients promotes early testing and timely autoimmune disease detection

3.2.3. Technological advancements enhance diagnostic accuracy and efficiency in autoimmune disease testing

3.3. Key industry pitfalls & challenges

3.3.1. High cost of advanced diagnostic tests limits accessibility in low-income regions

3.3.2. Lack of skilled professionals hampers diagnostic accuracy and service availability in healthcare

3.3.3. Limited awareness in rural areas leads to underdiagnosis and delayed autoimmune disease management

3.4. Market Opportunities

3.4.1. Expansion in emerging markets offers new opportunities for diagnostic test market growth

3.4.2. Integration of AI and machine learning enhances autoimmune disease diagnostic capabilities significantly

3.4.3. Development of multiplex assays allows simultaneous testing for multiple autoimmune conditions efficiently

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Autoimmune Disease Diagnostics Market, Product Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Consumables & Assay Kits

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Instruments

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Software & Services

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Autoimmune Disease Diagnostics Market, Test Type Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Test Type, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Antinuclear Antibody Tests

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Autoantibody Tests

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. C-Reactive Protein (CRP) Tests

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Erythrocyte Sedimentation Rate (ESR) Tests

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Complete Blood Count (CBC)

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.7. Others

5.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Autoimmune Disease Diagnostics Market, Technology Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Technology, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. ELISA

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Radioimmunoassay

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Immunofluorescence Assay

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Multiplex Assays

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Immuno

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Autoimmune Disease Diagnostics Market, Disease Type Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Disease Type, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Systemic Autoimmune Diseases

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.2. Rheumatoid Arthritis

7.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.3. Systemic Lupus Erythematosus

7.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.4. Sjögren’s Syndrome

7.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.5. Scleroderma

7.2.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Organ-Specific Autoimmune Diseases

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3.2. Type 1 Diabetes

7.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3.3. Hashimoto’s Thyroiditis

7.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3.4. Graves’ Disease

7.3.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3.5. Celiac Disease

7.3.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3.6. Multiple Sclerosis

7.3.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3.7. Others

7.3.8. Market Size and Forecast, 2025-2035 (USD Billion)

8. Autoimmune Disease Diagnostics Market, End-user Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By End-user, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Hospitals

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Clinical Laboratories

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Diagnostic Centers

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Research Institutes

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Autoimmune Disease Diagnostics Market, Region Segment Analysis

9.1. Overview

9.1.1. Global Market Revenue Share, By Region, 2025 & 2035

9.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

9.2. North America

9.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

9.2.2. North America Market Revenue, By Product, 2025-2035

9.2.3. North America Market Revenue, By Test Type, 2025-2035

9.2.4. North America Market Revenue, By Technology, 2025-2035

9.2.5. North America Market Revenue, By Disease Type, 2025-2035

9.2.6. North America Market Revenue, By End-user, 2025-2035

9.2.7. The U.S.

9.2.7.1. U.S. Market Revenue, By Product, 2025-2035

9.2.7.2. U.S. Market Revenue, By Test Type, 2025-2035

9.2.7.3. U.S. Market Revenue, By Technology, 2025-2035

9.2.7.4. U.S. Market Revenue, By Disease Type, 2025-2035

9.2.7.5. U.S. Market Revenue, By End-user, 2025-2035

9.2.8. Canada

9.2.8.1. Canada Market Revenue, By Product, 2025-2035

9.2.8.2. Canada Market Revenue, By Test Type, 2025-2035

9.2.8.3. Canada Market Revenue, By Technology, 2025-2035

9.2.8.4. Canada Market Revenue, By Disease Type, 2025-2035

9.2.8.5. Canada Market Revenue, By End-user, 2025-2035

9.3. Europe

9.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

9.3.2. Europe Market Revenue, By Product, 2025-2035

9.3.3. Europe Market Revenue, By Test Type, 2025-2035

9.3.4. Europe Market Revenue, By Technology, 2025-2035

9.3.5. Europe Market Revenue, By Disease Type, 2025-2035

9.3.6. Europe Market Revenue, By End-user, 2025-2035

9.3.7. Germany

9.3.7.1. Germany Market Revenue, By Product, 2025-2035

9.3.7.2. Germany Market Revenue, By Test Type, 2025-2035

9.3.7.3. Germany Market Revenue, By Technology, 2025-2035

9.3.7.4. Germany Market Revenue, By Disease Type, 2025-2035

9.3.7.5. Germany Market Revenue, By End-user, 2025-2035

9.3.8. France

9.3.8.1. France Market Revenue, By Product, 2025-2035

9.3.8.2. France Market Revenue, By Test Type, 2025-2035

9.3.8.3. France Market Revenue, By Technology, 2025-2035

9.3.8.4. France Market Revenue, By Disease Type, 2025-2035

9.3.8.5. France Market Revenue, By End-user, 2025-2035

9.3.9. U.K.

9.3.9.1. U.K. Market Revenue, By Product, 2025-2035

9.3.9.2. U.K. Market Revenue, By Test Type, 2025-2035

9.3.9.3. U.K. Market Revenue, By Technology, 2025-2035

9.3.9.4. U.K. Market Revenue, By Disease Type, 2025-2035

9.3.9.5. U.K. Market Revenue, By End-user, 2025-2035

9.3.10. Italy

9.3.10.1. Italy Market Revenue, By Product, 2025-2035

9.3.10.2. Italy Market Revenue, By Test Type, 2025-2035

9.3.10.3. Italy Market Revenue, By Technology, 2025-2035

9.3.10.4. Italy Market Revenue, By Disease Type, 2025-2035

9.3.10.5. Italy Market Revenue, By End-user, 2025-2035

9.3.11. Spain

9.3.11.1. Spain Market Revenue, By Product, 2025-2035

9.3.11.2. Spain Market Revenue, By Test Type, 2025-2035

9.3.11.3. Spain Market Revenue, By Technology, 2025-2035

9.3.11.4. Spain Market Revenue, By Disease Type, 2025-2035

9.3.11.5. Spain Market Revenue, By End-user, 2025-2035

9.3.12. Rest of Europe

9.3.12.1. Rest of Europe Market Revenue, By Product, 2025-2035

9.3.12.2. Rest of Europe Market Revenue, By Test Type, 2025-2035

9.3.12.3. Rest of Europe Market Revenue, By Technology, 2025-2035

9.3.12.4. Rest of Europe Market Revenue, By Disease Type, 2025-2035

9.3.12.5. Rest of Europe Market Revenue, By End-user, 2025-2035

9.4. Asia Pacific

9.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

9.4.2. Asia Pacific Market Revenue, By Product, 2025-2035

9.4.3. Asia Pacific Market Revenue, By Test Type, 2025-2035

9.4.4. Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.5. Asia Pacific Market Revenue, By Disease Type, 2025-2035

9.4.6. Asia Pacific Market Revenue, By End-user, 2025-2035

9.4.7. China

9.4.7.1. China Market Revenue, By Product, 2025-2035

9.4.7.2. China Market Revenue, By Test Type, 2025-2035

9.4.7.3. China Market Revenue, By Technology, 2025-2035

9.4.7.4. China Market Revenue, By Disease Type, 2025-2035

9.4.7.5. China Market Revenue, By End-user, 2025-2035

9.4.8. Japan

9.4.8.1. Japan Market Revenue, By Product, 2025-2035

9.4.8.2. Japan Market Revenue, By Test Type, 2025-2035

9.4.8.3. Japan Market Revenue, By Technology, 2025-2035

9.4.8.4. Japan Market Revenue, By Disease Type, 2025-2035

9.4.8.5. Japan Market Revenue, By End-user, 2025-2035

9.4.9. India

9.4.9.1. India Market Revenue, By Product, 2025-2035

9.4.9.2. India Market Revenue, By Test Type, 2025-2035

9.4.9.3. India Market Revenue, By Technology, 2025-2035

9.4.9.4. India Market Revenue, By Disease Type, 2025-2035

9.4.9.5. India Market Revenue, By End-user, 2025-2035

9.4.10. Australia

9.4.10.1. Australia Market Revenue, By Product, 2025-2035

9.4.10.2. Australia Market Revenue, By Test Type, 2025-2035

9.4.10.3. Australia Market Revenue, By Technology, 2025-2035

9.4.10.4. Australia Market Revenue, By Disease Type, 2025-2035

9.4.10.5. Australia Market Revenue, By End-user, 2025-2035

9.4.11. South Korea

9.4.11.1. South Korea Market Revenue, By Product, 2025-2035

9.4.11.2. South Korea Market Revenue, By Test Type, 2025-2035

9.4.11.3. South Korea Market Revenue, By Technology, 2025-2035

9.4.11.4. South Korea Market Revenue, By Disease Type, 2025-2035

9.4.11.5. South Korea Market Revenue, By End-user, 2025-2035

9.4.12. Singapore

9.4.12.1. Singapore Market Revenue, By Product, 2025-2035

9.4.12.2. Singapore Market Revenue, By Test Type, 2025-2035

9.4.12.3. Singapore Market Revenue, By Technology, 2025-2035

9.4.12.4. Singapore Market Revenue, By Disease Type, 2025-2035

9.4.12.5. Singapore Market Revenue, By End-user, 2025-2035

9.4.13. Rest of Asia Pacific

9.4.13.1. Rest of Asia Pacific Market Revenue, By Product, 2025-2035

9.4.13.2. Rest of Asia Pacific Market Revenue, By Test Type, 2025-2035

9.4.13.3. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

9.4.13.4. Rest of Asia Pacific Market Revenue, By Disease Type, 2025-2035

9.4.13.5. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

9.5. Latin America

9.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

9.5.2. Latin America Market Revenue, By Product, 2025-2035

9.5.3. Latin America Market Revenue, By Test Type, 2025-2035

9.5.4. Latin America Market Revenue, By Technology, 2025-2035

9.5.5. Latin America Market Revenue, By Disease Type, 2025-2035

9.5.6. Latin America Market Revenue, By End-user, 2025-2035

9.5.7. Brazil

9.5.7.1. Brazil Market Revenue, By Product, 2025-2035

9.5.7.2. Brazil Market Revenue, By Test Type, 2025-2035

9.5.7.3. Brazil Market Revenue, By Technology, 2025-2035

9.5.7.4. Brazil Market Revenue, By Disease Type, 2025-2035

9.5.7.5. Brazil Market Revenue, By End-user, 2025-2035

9.5.8. Argentina

9.5.8.1. Argentina Market Revenue, By Product, 2025-2035

9.5.8.2. Argentina Market Revenue, By Test Type, 2025-2035

9.5.8.3. Argentina Market Revenue, By Technology, 2025-2035

9.5.8.4. Argentina Market Revenue, By Disease Type, 2025-2035

9.5.8.5. Argentina Market Revenue, By End-user, 2025-2035

9.5.9. Mexico

9.5.9.1. Mexico Market Revenue, By Product, 2025-2035

9.5.9.2. Mexico Market Revenue, By Test Type, 2025-2035

9.5.9.3. Mexico Market Revenue, By Technology, 2025-2035

9.5.9.4. Mexico Market Revenue, By Disease Type, 2025-2035

9.5.9.5. Mexico Market Revenue, By End-user, 2025-2035

9.5.10. Rest of Latin America

9.5.10.1. Rest of Latin America Market Revenue, By Product, 2025-2035

9.5.10.2. Rest of Latin America Revenue, By Test Type, 2025-2035

9.5.10.3. Rest of Latin America Market Revenue, By Technology, 2025-2035

9.5.10.4. Rest of Latin America Market Revenue, By Disease Type, 2025-2035

9.5.10.5. Rest of Latin America Market Revenue, By End-user, 2025-2035

9.6. MEA

9.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

9.6.2. MEA Market Revenue, By Product, 2025-2035

9.6.3. MEA Market Revenue, By Test Type, 2025-2035

9.6.4. MEA Market Revenue, By Technology, 2025-2035

9.6.5. MEA Market Revenue, By Disease Type, 2025-2035

9.6.6. MEA Market Revenue, By End-user, 2025-2035

9.6.7. GCC Countries

9.6.7.1. GCC Countries Market Revenue, By Product, 2025-2035

9.6.7.2. GCC Countries Market Revenue, By Test Type, 2025-2035

9.6.7.3. GCC Countries Market Revenue, By Technology, 2025-2035

9.6.7.4. GCC Countries Market Revenue, By Disease Type, 2025-2035

9.6.7.5. GCC Countries Market Revenue, By End-user, 2025-2035

9.6.8. South Africa

9.6.8.1. South Africa Market Revenue, By Product, 2025-2035

9.6.8.2. South Africa Market Revenue, By Test Type, 2025-2035

9.6.8.3. South Africa Market Revenue, By Technology, 2025-2035

9.6.8.4. South Africa Market Revenue, By Disease Type, 2025-2035

9.6.8.5. South Africa Market Revenue, By End-user, 2025-2035

9.6.9. Rest of Middle-East & Africa

9.6.9.1. Rest of Middle-East & Africa Market Revenue, By Product, 2025-2035

9.6.9.2. Rest of Middle-East & Africa Market Revenue, By Test Type, 2025-2035

9.6.9.3. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

9.6.9.4. Rest of Middle-East & Africa Market Revenue, By Disease Type, 2025-2035

9.6.9.5. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

10. Company Profile

10.1. Abbott

10.1.1. Business Overview

10.1.2. Financial Performance

10.1.3. Product/Service Offerings

10.1.4. Strategies & recent developments

10.1.5. SWOT Analysis

10.2. bioMérieux

10.2.1. Business Overview

10.2.2. Financial Performance

10.2.3. Product/Service Offerings

10.2.4. Strategies & recent developments

10.2.5. SWOT Analysis

10.3. Bio-Rad Laboratories, Inc.

10.3.1. Business Overview

10.3.2. Financial Performance

10.3.3. Product/Service Offerings

10.3.4. Strategies & recent developments

10.3.5. SWOT Analysis

10.4. Siemens Healthineers AG

10.4.1. Business Overview

10.4.2. Financial Performance

10.4.3. Product/Service Offerings

10.4.4. Strategies & recent developments

10.4.5. SWOT Analysis

10.5. F. Hoffmann-La Roche Ltd

10.5.1. Business Overview

10.5.2. Financial Performance

10.5.3. Product/Service Offerings

10.5.4. Strategies & recent developments

10.5.5. SWOT Analysis

10.6. Quest Diagnostics

10.6.1. Business Overview

10.6.2. Financial Performance

10.6.3. Product/Service Offerings

10.6.4. Strategies & recent developments

10.6.5. SWOT Analysis

10.7. Thermo Fisher Scientific Inc.

10.7.1. Business Overview

10.7.2. Financial Performance

10.7.3. Product/Service Offerings

10.7.4. Strategies & recent developments

10.7.5. SWOT Analysis

10.8. Danaher Corporation

10.8.1. Business Overview

10.8.2. Financial Performance

10.8.3. Product/Service Offerings

10.8.4. Strategies & recent developments

10.8.5. SWOT Analysis

10.9. Trinity Biotech

10.9.1. Business Overview

10.9.2. Financial Performance

10.9.3. Product/Service Offerings

10.9.4. Strategies & recent developments

10.9.5. SWOT Analysis

10.10. EUROIMMUN Medizinische Labordiagnostika AG

10.10.1. Business Overview

10.10.2. Financial Performance

10.10.3. Product/Service Offerings

10.10.4. Strategies & recent developments

10.10.5. SWOT Analysis

10.11. Grifols SA

10.11.1. Business Overview

10.11.2. Financial Performance

10.11.3. Product/Service Offerings

10.11.4. Strategies & recent developments

10.11.5. SWOT Analysis

10.12. Myriad Genetics, Inc.

10.12.1. Business Overview

10.12.2. Financial Performance

10.12.3. Product/Service Offerings

10.12.4. Strategies & recent developments

10.12.5. SWOT Analysis

10.13. Exagen Inc.

10.13.1. Business Overview

10.13.2. Financial Performance

10.13.3. Product/Service Offerings

10.13.4. Strategies & recent developments

10.13.5. SWOT Analysis

10.14. Hologic, Inc.

10.14.1. Business Overview

10.14.2. Financial Performance

10.14.3. Product/Service Offerings

10.14.4. Strategies & recent developments

10.14.5. SWOT Analysis

10.15. PerkinElmer

10.15.1. Business Overview

10.15.2. Financial Performance

10.15.3. Product/Service Offerings

10.15.4. Strategies & recent developments

10.15.5. SWOT Analysis

10.16. Beckman Coulter, Inc.,

10.16.1. Business Overview

10.16.2. Financial Performance

10.16.3. Product/Service Offerings

10.16.4. Strategies & recent developments

10.16.5. SWOT Analysis

10.17. Fujirebio

10.17.1. Business Overview

10.17.2. Financial Performance

10.17.3. Product/Service Offerings

10.17.4. Strategies & recent developments

10.17.5. SWOT Analysis